Assistant professor of neurology, Harvard Medical School, and director, leukodystrophy service, Massachusetts General Hospital.
May 20, 2022
The director of the leukodystrophy service at Mass Gen discussed progress dosing in the phase 1/2 trial.
May 19, 2022
The director of the leukodystrophy service at Mass Gen discussed the phase 1/2 study of AXO-AAV-GM2.